Targeting Ferroptosis to Eliminate Senescent Cells: Mechanisms and Therapeutic Potential

Area of Science:

• Biomedical Science
• Cell Biology
• Aging Research

Background:

• Cellular senescence plays roles in development and tumor suppression but contributes to age-related diseases when cells accumulate.
• Senescent cells (SCs) exhibit irreversible cell cycle arrest, anti-apoptotic protein overexpression, and a senescence-associated secretory phenotype (SASP), leading to tissue dysfunction.
• Conventional senolytics targeting apoptosis have limitations, including poor selectivity and resistance from some SCs.

Purpose of the Study:

• To review the mechanisms of ferroptosis, an iron-dependent programmed cell death, as a senolytic strategy.
• To evaluate the therapeutic potential of ferroptosis for age-related pathologies.
• To highlight ferroptosis as a next-generation senolytic therapy.

Main Methods:

• Literature review focusing on ferroptosis induction in senescent cells.
• Analysis of molecular mechanisms involving iron, polyunsaturated fatty acids (PUFAs), and oxidative damage.
• Evaluation of ferroptosis's efficacy against age-related diseases like fibrosis, cancer, and neurodegeneration.

Main Results:

• Senescent cells can be effectively eliminated through ferroptosis due to their resistance to apoptosis.
• Ferroptosis leverages oxidative damage to overcome anti-apoptotic defenses in SCs.
• Elevated iron levels and PUFAs are key mediators in ferroptosis-driven elimination of SCs.

Conclusions:

• Ferroptosis presents a potent mechanism for clearing senescent cells, offering advantages over traditional apoptosis-inducing senolytics.
• Ferroptosis-based therapies show significant potential for treating diverse age-related conditions, including fibrosis, atherosclerosis, osteoarthritis, and neurodegeneration.
• Addressing translational challenges is crucial for realizing the full potential of ferroptosis as a next-generation senolytic approach for aging and related diseases.